|
Take a
self-assessment
survey.
Subscribe to
be notified about
added CME
activities or site
improvements.
Reading List
Screening Tools
Sleep University developed a case-based newsletter to correlate real-world issues in the management of insomnia with the kinds of patients who might be seen by primary care physicians, family physicians, internists, and OB/GYNs.
Please review the following Faculty information, and then select Step 3 to start the Activity.
Larry Culpepper, MD, MPH
Professor and Chairman, Department of Family Medicine
Boston University School of Medicine
Chief, Department of Family Medicine
Boston University Medical Center
Boston, MA
Susan G. Kornstein, MD
Professor of Psychiatry and Obstetrics and Gynecology
Executive Director, Institute for Women's Health
Executive Director, Mood Disorders Institute
Virginia Commonwealth University
Richmond, VA
Andrew D. Krystal, MD
Director of Sleep Research and the Insomnia Program
Associate Professor
Department of Psychiatry and Behavorial Sciences
Duke University School of Medicine
Durham, NC
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of The Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship that a faculty member or provider has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation.
Dr. Culpepper has disclosed the following financial relationships:
Consultant – Neurocrine, Takeda, Pfizer, Wyeth, Forest, Eli Lilly
Speaker's Bureau – Pfizer, Wyeth, Forest
Dr. Kornstein has disclosed the following financial relationships:
Consultant – Biovail Laboratories, Berlex, Bristol-Myers Squibb, Forest, Eli Lilly, Neurocrine, Pfizer, Sepracor, Wyeth
Grant/Research Support – Astra-Zeneca, Biovail Laboratories, Berlex, Boehringer-Ingelheim, Bristol-Myers Squibb, Department of Health and Human Services, Forest, GlaxoSmithKline, Merck, Mitsubishi-Tokyo Pharmaceuticals, Novartis, Pfizer, Sanofi-Synthelabo, Sepracor, Wyeth
Dr. Krystal has disclosed the following financial relationships:
Consultant – Actelion, Astellas, Astellas Research Triangle Institute, Arena, AstraZeneca, Axiom, Bristol-Myers Squibb, Cephalon, Eli Lilly, GlaxoSmithKline, Jazz, Johnson & Johnson, King, Merck, Neurocrine, Neurogen, Novartis, Organon, Pfizer, Respironics, Sanofi-Aventis, Sepracor, Somaxon, Takeda, TransOral
Grant/Research Support – Astellas, Cephalon, Evotec, GlaxoSmithKline, Merck, Neurocrine, Neurogen, Neuronetics, NIN, Pfizer, Sanofi-Aventis, Respironics, Sepracor, Somaxon, Takeda, TransOral
No faculty member has indicated that his or her presentation will include information on off-label products.
Adobe® Reader® is required for viewing this newsletter.
